Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients
about
Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignanciesInfluenza prevention and treatment in transplant recipients and immunocompromised hostsNewer influenza antivirals, biotherapeutics and combinations.Advances in antivirals for non-influenza respiratory virus infections.Blood and marrow transplant clinical trials network state of the Science Symposium 2014DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilationPhase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic reviewSymptomatic Respiratory Virus Infection and Chronic Lung Allograft DysfunctionDAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationUpdate in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients.Antiviral therapy for respiratory viral infections in immunocompromised patients.Parainfluenza 3 Infections Early After Kidney or Simultaneous Pancreas-Kidney Transplantation.Parainfluenza Virus in the Hospitalized Adult.Parainfluenza Virus 3-Specific T Cells: Opportunity for Intervention?Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.Novel antiviral agents for respiratory viral infection in immunocompromised adults.DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
P2860
Q26853131-CE92180F-90F4-4EC3-90B3-072C0334DB2FQ27011595-DF21DF94-1194-42D0-A297-9AA6F6966DDAQ30456363-DEAFD0A6-9A22-4921-825E-7AA4E6F0AEEFQ30457132-5DE333F7-5C70-4253-B9C5-8C6D13E0A8B1Q35591760-8D17D2A5-6E78-44D8-94BC-018CB83EA98FQ35749971-D28C92F7-DDF9-4EE5-82DB-211B41C5BB9FQ36264874-A3437A01-4BC3-48FF-AEE8-C3EEFD8A416BQ36386176-112E4EC9-AF52-41D7-A71B-E456D59151C2Q36446117-17C2EA5D-B1BC-452E-B5F2-21857771117DQ36568965-CBFA8A00-F3D0-402D-AD6E-A187604E3BD6Q36965855-42C2A341-F6E1-4A6B-8FEA-1FE12E338450Q38829076-17571E54-00B8-470F-9E25-04566D6D4014Q39076394-6DF61F22-6E39-4B40-9DBB-F0049039B59FQ39152726-9E2B61A7-C2CA-4A5D-9C5C-F2AC9CCD7A86Q40168808-04EEDBC3-EE48-485C-AC0E-E4A280D74C6CQ40215133-94B88F52-9FDA-4C08-967C-BDFDD6B5A825Q40449402-754E3584-67BE-4E48-BFD2-02CEFEBD6CBDQ41103203-3E193A39-EAD9-49F0-8A6D-69D1DAAF429DQ41873413-BF1B07E6-A2E7-4D0C-8458-265841F1934FQ41927260-24791DAB-0D5D-4563-B9F0-60551DE1FAFDQ42243405-771F7766-F8A5-4D91-8156-554F6539AB3BQ42280492-C703BA24-B397-4A48-8797-E6722C2CDF04
P2860
Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients
description
im Februar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 February 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2012
@uk
name
Clinical potential of DAS181 f ...... tions in transplant recipients
@en
Clinical potential of DAS181 f ...... tions in transplant recipients
@nl
type
label
Clinical potential of DAS181 f ...... tions in transplant recipients
@en
Clinical potential of DAS181 f ...... tions in transplant recipients
@nl
prefLabel
Clinical potential of DAS181 f ...... tions in transplant recipients
@en
Clinical potential of DAS181 f ...... tions in transplant recipients
@nl
P2093
P2860
P1476
Clinical potential of DAS181 f ...... tions in transplant recipients
@en
P2093
B B Guzmán-Suarez
E T Gilmore
M W Buckley
P2860
P304
P356
10.1111/J.1399-3062.2012.00718.X
P577
2012-02-16T00:00:00Z